All In Biotech

Drug Trial Radar · NCT00964886

Efficacy of Antidepressants in Chronic Back Pain

Last checked: Nov 20, 2026Latest source record: Nov 29, 2016 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 142 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

142

Actual

Start

Jan 2010

Primary completion

Dec 2014

Study completion Dec 2015

Sponsor

Lead sponsor
VA Office of Research and DevelopmentFederal agency
Sponsor type
Federal agency
Collaborators
University of California, San Diego
First posted
Aug 25, 2009

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 70 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This 12 week placebo controlled clinical trial tests the individual and combined effects of an antidepressant medication and cognitive behavioral therapy for chronic back pain.

Conditions

  • Back Pain

Interventions

  • cognitive behavioral therapyBehavioral

    cognitive behavioral therapy, a type of psychotherapy oriented towards restoring function and reducing impact of pain on everyday life

  • desipramine hydrochlorideDrug

    desipramine hydrochloride, with dose targeted to achieve a serum concentration of 5-60ng/ml

  • cognitive behavioral therapyBehavioral

    cognitive behavioral therapy, a type of psychotherapy oriented towards restoring function and reducing impact of pain on everyday life

  • benztropine mesylate 0.125 mg dailyDrug

    benztropine mesylate is a placebo, some of whose side effects mimic those of experimental intervention, desipramine hydrochloride

  • desipramine hydrochlorideDrug

    desipramine hydrochloride, with dose targeted to achieve a serum concentration of 5-60ng/ml

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Intent-toTreat Analysis of Descriptor Differential Scale (DDS) of Pain IntensityTime frame: 12 weeks after baseline (or last observation carried forward)

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • VA San Diego Healthcare System, San Diego, CA

    San Diego, California

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.